FDA Inspection 850579 — Jubilant HollisterStier General Partnership

Jubilant HollisterStier General Partnership — FEI 3001623073

The FDA completed an inspection of Jubilant HollisterStier General Partnership on September 26, 2013 in Kirkland. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 26, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kirkland (Canada)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
116221 CFR 211.28(a)Protective Apparel Not Worn
121521 CFR 211.67(b)Written procedures not established/followed
360321 CFR 211.160(b)Scientifically sound laboratory controls